Drugmaker Lupin Shuts Manufacturing Plant
Around 17 Staff Test Covid-19 Positive
Two government officials said on Tuesday that after at least 17 employees at the company Lupin’s site tested positive for COVID-19, the drugmaker Lupin Ltd has shut one of its manufacturing plants in Gujarat.
According to the company Lupin’s website, at the Ankleshwar site in Gujarat state, the company has around 11 manufacturing plants, which is spread out over 40 acres and has 984 employees.
A senior district official, MD Modia said that, in recent days, employees from one of those plants, which produces tuberculosis drugs, have tested positive.
He said, “After the cases were confirmed, the plant was shut on July 12. The site has since been sanitized and that the operations of other plants in the facility are unaffected as there are no cases been reported from other plants.”
Another senior government official from the Bharuch district said that other employees who have come in contact with those who have tested positive are also in the process of being tested.
Lupin, an Indian multinational pharmaceutical company is one of the leading global pharmaceutical company and it sells its products in over 100 countries, with its largest market
being North America and makes everything from heart drugs to asthma and diabetes medicines.The COVID-19 pandemic has caused panic and significant economic damage across the world as the infection causing virus SARS-CoV-2 has resulted in 130,70,097 cases and 5,72,411 deaths globally as of July 14, 2020. India became the third country with the highest number of COVID-19 cases after the United States and Brazil. With around 9,06,752 cases reported and 23,727 deaths in the country, India’s recovery rate is continuously increasing as the number of recovered cases stands at 5,71,459. Researchers all around the world are racing to develop antiviral drugs and a vaccine to fight against the pandemic
Source
Drugmaker Lupin Shuts Manufacturing Plant After Around 17 Staff Test Covid-19 Positive
